Exploring the Practice of Clinical Pharmacists Participating in Fine Management of Neurology Pharmacy Under the Background of DRG
Objective:To explore the effect of clinical pharmacists participating in the fine management of neurology pharmacy under the background of DRG(Diagnosis Related Groups).Methods:The discharged patients who entered the DRG disease groups in the Department of Neurology of Guilin People's Hospital from 2021 to 2022 were selected as the research objects.The changes of main DRG indexes and pharmaceutical management indexes of patients before(2021)and after(2022)intervention of clinical pharmacists participating in the fine management of neurology pharmacy were compared.Cost analysis was carried out for the key DRG groups with the top 5 in the number of enrolled cases.The rationality of medication was evaluated in the DRG disease groups with hospitalization expenses exceeding 2 times the payment standard of the benchmark hospital.Results:After intervention,the case mix index of neurology department increased,and the cost consumption index,time consumption index,average hospitalization expenses and average hospitalization days were significantly lower than those before intervention(P＜0.05).The proportion of drugs,the proportion of auxiliary drugs and the average drug expenses per time were significantly lower than those before the intervention(P＜0.05).Among the top 5 DRG disease groups,the average hospitalization expenses and average drug expenses per time of BR23,BR21,BM19 and BX29 disease groups were significantly lower than those before intervention(P＜0.05).After clinical pharmacists intervened in DRG overspending cases,the overspending rate and unreasonable rate decreased significantly(P＜0.05).Conclusion:Clinical pharmacists participate in the fine management of neurology pharmacy based on DRG,which is helpful to improve the medical quality,service efficiency and rational drug use level of clinical departments,and provides reference for promoting DRG payment reform.
NETL
NSTL
万方数据
